Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Fox

Showing results (221-230 of 1,557) with videos related to

Pageof 156
Sort By:
FEBS Letters|February 1, 1974
Sodium dithionite reduction of flavinJ L Fox
American Journal of Ophthalmology|April 1, 1974
Correspondence: Lorgnette occluderS L Fox
Burns, Including Thermal Injury|April 1, 1985
The human pharmacology of silver sulphadiazine (AgSD)C L Fox
Health Care Management Review|January 1, 1989
Vertical integration strategies: more promising than diversificationW L Fox
The Orthopedic Clinics of North America|July 1, 1977
Physical training: methods and effectsE L Fox
Nature Biotechnology|April 1, 2003
FDA panel recommends easing gene therapy trial limitsJeffrey L Fox
Nature Biotechnology|November 28, 2002
Surprise US election results may boost biotechJeffrey L Fox
Nature Biotechnology|November 28, 2002
Agbiotech issues climb US political agendaJeffrey L Fox
Nature Biotechnology|February 1, 2003
US policy on data disclosure debatedJeffrey L Fox
Nature Biotechnology|September 3, 2002
US legislation could boost renewable fuel and materials usesJeffrey L Fox
Pageof 156

Showing results (221-230 of 1,557) with videos related to

Sort By:
Pageof 156
FEBS Letters|February 1, 1974
Sodium dithionite reduction of flavinJ L Fox
American Journal of Ophthalmology|April 1, 1974
Correspondence: Lorgnette occluderS L Fox
Burns, Including Thermal Injury|April 1, 1985
The human pharmacology of silver sulphadiazine (AgSD)C L Fox
Health Care Management Review|January 1, 1989
Vertical integration strategies: more promising than diversificationW L Fox
The Orthopedic Clinics of North America|July 1, 1977
Physical training: methods and effectsE L Fox
Nature Biotechnology|April 1, 2003
FDA panel recommends easing gene therapy trial limitsJeffrey L Fox
Nature Biotechnology|November 28, 2002
Surprise US election results may boost biotechJeffrey L Fox
Nature Biotechnology|November 28, 2002
Agbiotech issues climb US political agendaJeffrey L Fox
Nature Biotechnology|February 1, 2003
US policy on data disclosure debatedJeffrey L Fox
Nature Biotechnology|September 3, 2002
US legislation could boost renewable fuel and materials usesJeffrey L Fox
Pageof 156